Ernexa Therapeutics Inc. Operating Leases, Future Minimum Payments Due
Ernexa Therapeutics Inc. (ERNA) had Operating Leases, Future Minimum Payments Due of $4.55 million as of 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDue · last filed 2019-03-22
- 2018-12-31: Operating Leases, Future Minimum Payments Due $4.55M.
- 2018-08-31: Operating Leases, Future Minimum Payments Due $4.49M.
- 2017-12-31: Operating Leases, Future Minimum Payments Due $634.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments Due $1.25M.
| Period end | Operating Leases, Future Minimum Payments Due |
|---|---|
| 2018-12-31 | $4.55M 10-K · filed 2019-03-22 |
| 2018-08-31 | $4.49M 10-Q · filed 2018-11-09 |
| 2017-12-31 | $634.00K 10-K · filed 2018-03-09 |
| 2016-12-31 | $1.25M 10-K · filed 2017-03-09 |
| 2015-12-31 | $1.99M 10-K · filed 2016-03-15 |
| 2014-12-31 | $2.75M 10-K · filed 2015-03-27 |
| 2013-12-31 | $3.32M 10-K · filed 2014-03-31 |
| 2012-12-31 | $3.98M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |